Earlier this month, amid a deadly dengue outbreak, it looked as if the Philippines might start using Sanofi's Dengvaxia again. But that's off the table because Sanofi failed to live up to its post-marketing commitments, health officials there said this week.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,